These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 20634263)

  • 41. [Which equipment for proton therapy of the future?].
    Schwartz LH; Laisne A; Ivanov AA; Mandrillon P; Chauvel P; Mazal A; Habrand JL; Tronc D; Baccal M; Laugier A
    Bull Cancer Radiother; 1995; 82(4):365-9. PubMed ID: 8554889
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The potential of proton beam radiation therapy in head and neck cancer.
    Ask A; Björk-Eriksson T; Zackrisson B; Blomquist E; Glimelius B
    Acta Oncol; 2005; 44(8):876-80. PubMed ID: 16332595
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The potential of proton beam radiation therapy in gastrointestinal cancer.
    Ask A; Johansson B; Glimelius B
    Acta Oncol; 2005; 44(8):896-903. PubMed ID: 16332599
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dose conformation of intensity-modulated stereotactic photon beams, proton beams, and intensity-modulated proton beams for intracranial lesions.
    Baumert BG; Norton IA; Lomax AJ; Davis JB
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1314-24. PubMed ID: 15519805
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The potential of proton beam radiation therapy in lung cancer (including mesothelioma).
    Bjelkengren G; Glimelius B
    Acta Oncol; 2005; 44(8):881-3. PubMed ID: 16332596
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Spot-scanning proton radiation therapy for recurrent, residual or untreated intracranial meningiomas.
    Weber DC; Lomax AJ; Rutz HP; Stadelmann O; Egger E; Timmermann B; Pedroni ES; Verwey J; Miralbell R; Goitein G;
    Radiother Oncol; 2004 Jun; 71(3):251-8. PubMed ID: 15172139
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The potential of proton beam radiation therapy in prostate cancer, other urological cancers and gynaecological cancers.
    Johansson B; Ridderheim M; Glimelius B
    Acta Oncol; 2005; 44(8):890-5. PubMed ID: 16332598
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison between in-beam and offline positron emission tomography imaging of proton and carbon ion therapeutic irradiation at synchrotron- and cyclotron-based facilities.
    Parodi K; Bortfeld T; Haberer T
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):945-56. PubMed ID: 18514787
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Feasibility of using internal radiation-generating devices in radiotherapy.
    Bevelacqua JJ
    Health Phys; 2010 Apr; 98(4):614-20. PubMed ID: 20220369
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The proton beam debate: are facilities outstripping the evidence?
    Goozner M
    J Natl Cancer Inst; 2010 Apr; 102(7):450-3. PubMed ID: 20339139
    [No Abstract]   [Full Text] [Related]  

  • 51. Technology for proton therapy.
    Flanz J; Smith A
    Cancer J; 2009; 15(4):292-7. PubMed ID: 19672145
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical results of proton beam therapy for cancer of the esophagus.
    Sugahara S; Tokuuye K; Okumura T; Nakahara A; Saida Y; Kagei K; Ohara K; Hata M; Igaki H; Akine Y
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):76-84. PubMed ID: 15629597
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Conformational radiotherapy for bladder cancer: limits to precision and potential advantages of the utilization of proton beams].
    Miralbell R
    Arch Esp Urol; 1999; 52(6):684-91. PubMed ID: 10484852
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Proton therapy in Japan.
    Tsunemoto H; Morita S; Ishikawa T; Furukawa S; Kawachi K; Kanai T; Ohara H; Kitagawa T; Inada T
    Radiat Res Suppl; 1985; 8():S235-43. PubMed ID: 3003785
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dosimetry of clinical neutron and proton beams: an overview of recommendations.
    Vynckier S; ;
    Radiat Prot Dosimetry; 2004; 110(1-4):565-72. PubMed ID: 15353710
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Selection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approach.
    Langendijk JA; Lambin P; De Ruysscher D; Widder J; Bos M; Verheij M
    Radiother Oncol; 2013 Jun; 107(3):267-73. PubMed ID: 23759662
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Tandetron™ as proton injector for the eye tumor therapy in Berlin.
    Röhrich J; Damerow T; Hahn W; Müller U; Reinholz U; Denker A
    Rev Sci Instrum; 2012 Feb; 83(2):02B903. PubMed ID: 22380335
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proton beam therapy.
    Levin WP; Kooy H; Loeffler JS; DeLaney TF
    Br J Cancer; 2005 Oct; 93(8):849-54. PubMed ID: 16189526
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Proton therapy on locally advanced cancer].
    Fuwa N
    Gan To Kagaku Ryoho; 2009 Nov; 36(11):1788-90. PubMed ID: 19920378
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.